PuraPharm Corporation Limited (1498.HK)
HKD 0.55
(-3.51%)
HKD 0.55
(-3.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 406.85 Million | 448.06 Million | 659.59 Million | 601.81 Million | 695.87 Million | 745.5 Million |
| Cost of Revenue | 190.23 Million | 187.48 Million | 237.74 Million | 233.12 Million | 298.28 Million | 290.6 Million |
| Gross Profit | 216.62 Million | 260.58 Million | 421.85 Million | 368.68 Million | 397.59 Million | 454.9 Million |
| Operating Expenses | 216.62 Million | 325.08 Million | 404.23 Million | 373.56 Million | 458.83 Million | 406.92 Million |
| Selling, General and Administrative Expenses | 263.17 Million | 303.52 Million | 380.28 Million | 352.78 Million | 425.35 Million | 447.02 Million |
| Research and Development Expenses | 16.77 Million | 20.2 Million | 23.95 Million | 20.77 Million | 33.48 Million | 26.36 Million |
| Other Expenses | - | -1.36 Million | -51.17 Million | 849 Thousand | -34 Million | 20.66 Million |
| Cost and Expenses | 472.9 Million | 512.56 Million | 641.97 Million | 606.69 Million | 757.12 Million | 697.52 Million |
| Operating Income | -66.04 Million | -64.5 Million | 17.61 Million | -4.87 Million | -61.24 Million | 9.24 Million |
| Interest Expense | 27.4 Million | 24.18 Million | 27.02 Million | 30.55 Million | 31 Million | 24.72 Million |
| Income Tax Expense | 3.76 Million | 1.03 Million | 4.68 Million | 8.5 Million | 11.1 Million | 5.72 Million |
| Earnings before Tax | -102.31 Million | -119.18 Million | -117.19 Million | 40.21 Million | -216.15 Million | 26.53 Million |
| Net Income | -106.08 Million | -120.21 Million | -121.87 Million | 31.71 Million | -227.25 Million | 20.8 Million |
| Earnings Per Share Basic | -0.27 | -0.30 | -0.31 | 0.09 | -0.82 | 0.08 |
| Earnings Per Share Diluted | -0.27 | -0.30 | -0.31 | 0.09 | -0.82 | 0.08 |
| Weighted Average Shares Outstanding | 395.05 Million | 394.58 Million | 393.73 Million | 370.84 Million | 276.08 Million | 246.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 395.05 Million | 394.58 Million | 393.73 Million | 371.41 Million | 276.08 Million | 246.5 Million |
| Gross Margin | 0.53 | 0.58 | 0.64 | 0.61 | 0.57 | 0.61 |
| EBIT Margin | -0.06 | -0.04 | 0.10 | 0.07 | 0.01 | 0.06 |
| Profit Margin | -0.26 | -0.27 | -0.18 | 0.05 | -0.33 | 0.03 |
| EBITDA | -26.16 Million | -46.33 Million | -40.02 Million | 114.67 Million | -122.19 Million | 85.7 Million |
| Earnings Before Tax Margin | -0.16 | -0.14 | 0.03 | -0.01 | -0.09 | 0.01 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 207.62 Million | 406.85 Million | 211.77 Million | 195.08 Million | 448.06 Million | 217.3 Million |
| Cost of Revenue | 94.36 Million | 192.01 Million | 107.67 Million | 84.34 Million | 187.48 Million | 105.92 Million |
| Gross Profit | 113.26 Million | 214.84 Million | 104.1 Million | 110.73 Million | 260.58 Million | 111.38 Million |
| Operating Expenses | 120.24 Million | 266.42 Million | 136.78 Million | 129.63 Million | 325.08 Million | 165.68 Million |
| Selling, General and Administrative Expenses | 114.64 Million | - | 127.93 Million | 121.2 Million | - | 153.54 Million |
| Research and Development Expenses | 5.59 Million | - | 6.54 Million | 8.43 Million | - | 12.14 Million |
| Other Expenses | - | -2.3 Million | -2.3 Million | - | -1.36 Million | - |
| Cost and Expenses | 214.61 Million | 458.44 Million | 244.46 Million | 213.98 Million | 512.56 Million | 271.61 Million |
| Operating Income | -6.98 Million | -51.58 Million | -32.68 Million | -18.9 Million | -64.5 Million | -54.3 Million |
| Interest Expense | 13.25 Million | 27.4 Million | 14.05 Million | 13.34 Million | 24.18 Million | 10.18 Million |
| Income Tax Expense | 3.92 Million | 3.76 Million | 2.6 Million | 1.16 Million | 1.03 Million | -4.17 Million |
| Earnings before Tax | -14.76 Million | -102.16 Million | -65.79 Million | -36.51 Million | -119.18 Million | -84.48 Million |
| Net Income | -18.68 Million | -106.08 Million | -68.4 Million | -37.67 Million | -120.21 Million | -80.31 Million |
| Earnings Per Share Basic | -0.05 | - | -0.17 | -0.10 | - | -0.20 |
| Earnings Per Share Diluted | -0.05 | - | -0.17 | -0.10 | - | -0.20 |
| Weighted Average Shares Outstanding | 395.06 Million | 395.05 Million | 395.05 Million | 395.05 Million | 394.58 Million | 395.05 Million |
| Weighted Average Shares Outstanding (Diluted) | 395.05 Million | 395.05 Million | 395.05 Million | 395.05 Million | 394.58 Million | 395.05 Million |
| Gross Margin | 0.55 | 0.53 | 0.49 | 0.57 | 0.58 | 0.51 |
| EBIT Margin | 0.02 | - | -0.03 | 0.01 | - | -0.16 |
| Profit Margin | -0.09 | -0.26 | -0.32 | -0.19 | -0.27 | -0.37 |
| EBITDA | 4.43 Million | - | -5.47 Million | 2.48 Million | - | -33.94 Million |
| Earnings Before Tax Margin | -0.03 | -0.13 | -0.15 | -0.10 | -0.14 | -0.25 |
002936
600615
BC
AMLTF
2612
APXYY